Search - tctmd.com

Displaying 321 - 340 of 868

Sort: Relevancy | Date

Presentation TCT 2017

Metallic DES Are Different! How I Choose Stent Type to Match the Lesion and Patient (From 30 Years of Experience)

Presenter: Giulio G. Stefanini, Stephan Windecker, Antonio Colombo

October 30, 2017

Presentation TCT 2017

Are All Contemporary DES Comparable? Lessons From the SCAAR Registry

Presenter: Giulio G. Stefanini, Stephan Windecker, Stefan K. James

October 30, 2017

Presentation TCT 2017

Are All Contemporary DES Comparable? Lessons From the COMPARE Trials

Presenter: Giulio G. Stefanini, Stephan Windecker, Elvin Kedhi

October 30, 2017

Presentation TCT 2017

BioNIR: Specifications and BIONICS/NIREUS Results in Perspective

Presenter: Stephen G. Ellis, David E. Kandzari

October 30, 2017

Presentation TCT 2017

Are All Contemporary DES Comparable? Lessons From the TWENTE Trials

Presenter: Giulio G. Stefanini, Stephan Windecker, Clemens von Birgelen

October 30, 2017

Presentation TCT 2017

Resolute and Onyx Zotarolimus-Eluting Stents: Device Iterations and Randomized/Registry Outcomes Data in Perspective

Presenter: Stephen G. Ellis, David E. Kandzari, Matthew J. Price

October 30, 2017

Presentation TCT 2017

Are All Contemporary DES Comparable? Lessons From the SORT-OUT Trials

Presenter: Giulio G. Stefanini, Stephan Windecker, Evald H. Christiansen

October 30, 2017

Presentation TCT 2017

When Two Stents Are Indicated: DK Crush Technique Step-by-step (With Case Examples)

Presenter: Terje K. Steigen, Leif Thuesen, Nai-Liang Tian

October 30, 2017

Presentation TCT 2017

Are There Meaningful Differences Between Current Durable Polymer-Based vs Bioabsorbable Polymer-Based vs Polymer-Free Metallic DES? Pathologic Insights

Presenter: Giulio G. Stefanini, Stephan Windecker, Renu Virmani

October 30, 2017

Presentation TCT 2017

Promus Element Everolimus-Eluting Stents: Device Iterations and Randomized/Registry Outcomes Data in Perspective

Presenter: Stephen G. Ellis, David E. Kandzari, Sigmund Silber

October 30, 2017

Presentation TCT 2017

When Two Stents Are Indicated: TAP Technique Step-by-step (With Case Examples)

Presenter: Terje K. Steigen, Leif Thuesen, Francesco Burzotta

October 30, 2017

Presentation TCT 2017

When Two Stents Are Indicated: Culotte Technique Step-by-step (With Case Examples)

Presenter: Terje K. Steigen, Leif Thuesen, Ioannis Iakovou

October 30, 2017

Presentation TCT 2017

XIENCE Everolimus-Eluting Stents: Device Iterations, Randomized/Registry Outcomes Data in Perspective and the Move to Shorter DAPT

Presenter: Stephen G. Ellis, David E. Kandzari, Tullio Palmerini

October 30, 2017

Presentation TCT 2017

Mortality and Stroke After PCI vs CABG In Left Main and 3VD: An Individual Patient Data Meta-analysis

Presenter: Dean J. Kereiakes, Spencer B. King III, A. Pieter Kappetein

October 30, 2017

Presentation TCT 2017

Influence of Diversity: Should Sex, Race, and Ethnicity Affect Revascularization Decisions? Does It?

Presenter: Dean J. Kereiakes, Spencer B. King III, Roxana Mehran

October 30, 2017

Presentation TCT 2017

My Stepwise Approach to Bifurcations to Decide Between 1 and 2 Stents (With Case Examples)

Presenter: Terje K. Steigen, Leif Thuesen, Yves R. Louvard

October 30, 2017

Presentation TCT 2017

Impact of Mandatory Stent Price Controls 2: My New Insights From Inside Industry

Presenter: Dean J. Kereiakes, Spencer B. King III, Ian T. Meredith

October 30, 2017

Presentation TCT 2017

Bifurcation Stents 1: TRYTON Description, Data, and Case Examples

Presenter: Alaide Chieffo, Jeffrey W. Moses, Philippe Genereux

October 30, 2017

Presentation TCT 2017

Impact of Mandatory Stent Price Controls 1: Physician Perspectives

Presenter: Dean J. Kereiakes, Spencer B. King III, Upendra Kaul

October 30, 2017

Presentation TCT 2017

Treatment of Coronary Bifurcations in the Contemporary Era of P2Y12 Inhibitors and "Biologically Active Stents"

Presenter: Davide Capodanno, David Hildick-Smith, Marco Zimarino

October 30, 2017

Advertisement

Metallic DES Are Different! How I Choose Stent Type to Match the Lesion and Patient (From 30 Years of Experience)

Are All Contemporary DES Comparable? Lessons From the SCAAR Registry

Are All Contemporary DES Comparable? Lessons From the COMPARE Trials

BioNIR: Specifications and BIONICS/NIREUS Results in Perspective

Are All Contemporary DES Comparable? Lessons From the TWENTE Trials

Resolute and Onyx Zotarolimus-Eluting Stents: Device Iterations and Randomized/Registry Outcomes Data in Perspective

Are All Contemporary DES Comparable? Lessons From the SORT-OUT Trials

When Two Stents Are Indicated: DK Crush Technique Step-by-step (With Case Examples)

Are There Meaningful Differences Between Current Durable Polymer-Based vs Bioabsorbable Polymer-Based vs Polymer-Free Metallic DES? Pathologic Insights

Promus Element Everolimus-Eluting Stents: Device Iterations and Randomized/Registry Outcomes Data in Perspective

When Two Stents Are Indicated: TAP Technique Step-by-step (With Case Examples)

When Two Stents Are Indicated: Culotte Technique Step-by-step (With Case Examples)

XIENCE Everolimus-Eluting Stents: Device Iterations, Randomized/Registry Outcomes Data in Perspective and the Move to Shorter DAPT

Mortality and Stroke After PCI vs CABG In Left Main and 3VD: An Individual Patient Data Meta-analysis

Influence of Diversity: Should Sex, Race, and Ethnicity Affect Revascularization Decisions? Does It?

My Stepwise Approach to Bifurcations to Decide Between 1 and 2 Stents (With Case Examples)

Impact of Mandatory Stent Price Controls 2: My New Insights From Inside Industry

Bifurcation Stents 1: TRYTON Description, Data, and Case Examples

Impact of Mandatory Stent Price Controls 1: Physician Perspectives

Treatment of Coronary Bifurcations in the Contemporary Era of P2Y12 Inhibitors and "Biologically Active Stents"

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content